SGS Life Sciences
Also known as: Clinical Pharmacology Unit Antwerp, Belgium | Clinical Pharmacology Unit at SGS Life Sciences - Antwerpen (Belgium) | Life Science Services SGS Belgium NV | SGS Antwerpen | SGS Antwerpen, Belgium | SGS Aster | SGS Aster-Cephac | SGS Aster-Cephac (CRO) | SGS Aster Life Science Services - Paris-France | SGS Aster, Paris, France | SGS Aster S.A.S. | SGS Aster S.A.S., Phase I Clinical Unit, France | SGS Belgium NV | SGS Clinical Pharmacology Unit | SGS Life Sciences | SGS Life Sciences, a division of SGS Belgium NV | SGS LSS Clinical Pharmacology Unit Antwerp | SGS LSS Clinical Pharmacology Unit Antwerpen | SGS LSS Clinical Pharmacology Unit - Antwerpen | SGS S.A. | SGS Stephens, Inc. Dallas Research Center | SGS Stuivenberg | SGS U.S. Testing Company Inc. | Stephens SGS, Inc.
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2005Last known activity
Feb 6, 2025
Timeline
1870s
- Jun 1, 1878
SGS Life Sciences— Founded
2000s
- Jan 5, 2006
Aster-Cephac— Acquired
Drugs by trial phase (58 distinct, 64 trials)
Phase 4 (1 own, 1 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (43 own, 1 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Arthralgia
- Arthritis
- Arthritis, Rheumatoid
- Bronchiectasis
- Campylobacter Infections
- Cardiovascular Diseases
- Communicable Diseases
- Cystic Fibrosis
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Dyslipidemias
- Epilepsies, Partial
- Epilepsy
- Erectile Dysfunction
- Fatigue
- Fibrosis
- Genetic Diseases, Inborn
- Hepatitis
- Hepatitis B
- Hypoglycemia
- Infections
- Influenza, Human
- Kidney Failure, Chronic
- Malaria
- Malaria, Falciparum
- Metabolic Diseases
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Osteoarthritis, Knee
- Parasitemia
- Parasitic Diseases
- Primary Myelofibrosis
- Protozoan Infections
- Raynaud Disease
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Sclerosis
- Trypanosomiasis
- Trypanosomiasis, African
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT07066150CollaboratorN/AFeb 6, 2025
- NCT05898984CollaboratorPhase 1Apr 24, 2023
- NCT05712876CollaboratorPhase 1Dec 26, 2022
- NCT05012735Overall official - principal investigatorPhase 1Jul 19, 2021
- NCT04310085CollaboratorPhase 1Mar 18, 2020
- NCT04388176CollaboratorPhase 2Jan 3, 2020
- NCT04385420Overall official - principal investigatorPhase 1Apr 24, 2019
- NCT04385420CollaboratorPhase 1Apr 24, 2019
- NCT03883113Overall official - principal investigatorPhase 2Apr 2, 2019
- NCT03707041CollaboratorPhase 1Dec 11, 2018
- NCT03707041Overall official - principal investigatorPhase 1Dec 11, 2018
- NCT03439072CollaboratorPhase 3Jan 23, 2018
- NCT03309605CollaboratorPhase 1Oct 11, 2017
- NCT03292302CollaboratorPhase 1Sep 26, 2017
- NCT03657264Overall official - principal investigatorPhase 1Aug 21, 2017
Details
- Founded
- Geneva, CH Jun 1, 1878
- Last known activity
- Feb 6, 2025
Notes
CRO